For 3Q25, the Macquarie Small Cap Value Fund Institutional class shares lagged the stronger return of its benchmark, the ...

The market opportunity lies in enhancing proposal crafting skills to increase win rates by aligning offers with customer criteria, reducing legal risks, and effectively managing bids. This course ...

Phoenix, AZ — December 2025 — This Christmas, Phoenix families and businesses can give a gift that… At U & Improved, we believe leadership isn’t a title, it’s a mindset. Our… Join us as we unveil the ...

TEBE-AM is a Phase III randomized trial in melanoma patients who have progressed on checkpoints and targeted therapy.